Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d
Bayesian regression models for cost-effectiveness analysis
✍ Scribed by Francisco-José Vázquez Polo; Miguel Negrín; Xavier Badía; Montse Roset
- Publisher
- Springer
- Year
- 2005
- Tongue
- French
- Weight
- 756 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1618-7598
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We consider the problem of assessing new and existing technologies for their cost‐effectiveness in the case where data on both costs and effects are available from a clinical trial, and we address it by means of the cost‐effectiveness acceptability curve. The main difficulty in these an
A model creates the framework for a cost-e!ectiveness analysis, allowing decision makers to explore the implications of using an intervention in di!erent ways and under di!erent conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the fact
We consider the Bayesian D-optimal design problem for exponential growth models with one. two or three parameters. For the one-parameter model conditions on the shape of the density of the prior distribution and on the range of its support are given guaranteeing that a one-point design is also Bayes